Pursuant to section 23(1) of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
Product: Utrogestan
Active Ingredient: Progesterone 100mg
Dosage Form: Capsule
New Zealand Sponsor: Pharmaco (NZ) Limited
Manufacturers: Capsugel, Zone Industrielle de Camagnon, Ploermel, France
Catalent France Beinheim S.A., Beinheim, France
Note: This consent is valid for two years from the date of publication of this notice.
Dated this 30th day of March 2009.
JOHN HAZELDINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).